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Abstract
Background: Central precocious puberty (CPP) is often familial but its genetic cause is largely unknown. Very
recently, the makorin RING finger protein 3 (MKRN3) gene, located on chromosome 15 in the Prader-Willi syndrome
(PWS)-associated region (15q11-q13), has been found mutated in 5 families with familial precocious puberty. The
MKRN3 is a maternal imprinted gene and the phenotype is expressed only when the MKRN3 mutations are
localized on the allele inherited from the father. The function of this gene is not completely known and the
phenotype caused by its defect is not yet fully elucidated. We report a new MKRN3 mutation (Pro160Cysfs*14)
causing familial CPP.
Case presentation: The index case is a 7 years old girl showing Tanner stage 3 and pubic hair stage 1. Her bone
age evaluated by TW2 method was 10.3 years. Her hormonal data confirmed the diagnosis of central precocious
puberty. Familial medical history revealed precocious puberty in a cousin on paternal side. Paternal grandmother
had menarche at the age of 9 years and 6 months and premature menopause when she was 36 years old. Genetic
analysis revealed a new mutation (c477_485del; Pro160Cysfs*14) in the maternally imprinted MKRN3. Puberty onset
was at 5 years in the other affected female family member. Precocious puberty was well controlled by
pharmacological therapy.
Conclusion: We expand the number of the MKRN3 mutations associated with CPP and highlight the importance of
an accurate family medical history to disclose the peculiar pattern of inheritance of this gene.
Background
Pubertal timing is influenced by complex interplay among
genetic, nutritional, environmental and socioeconomic
factors [1, 2]. Population-based studies have provided
compelling evidence supporting genetic effects on puber-
tal timing [3].
Central precocious puberty (CPP) is defined by the
gonadotropin-dependent development of secondary sex-
ual characteristics before the age of 8 years in girls and
9 years in boys. CPP is familial in about 25 % of cases,
showing an autosomal dominant transmission with
incomplete, sex dependent, penetrance [4]. Although
recent genome-wide association studies have identified
several loci associated with pubertal timing and age at
menarche, the genetic causes of CPP are still largely
unknown.
Mutations in the genes encoding kisspeptin I and its
receptor represent the first identified genetic causes of
CPP [5, 6]. Very recently, the makorin RING finger
protein 3 (MKRN3) gene, located on chromosome 15 in
the Prader-Willi syndrome (PWS)-associated region
(15q11-q13), has been found mutated in 5 families with
familial precocious puberty [7]. MKRN3 is a maternal
imprinted gene that is expressed only if transmitted
from the father. Accordingly, MKRN3 mutations are
not associated with pathological phenotype if transmit-
ted from the mother [8].
The function of this gene is not completely known.
Probably, it is involved in the ubiquitination of the pro-
teins and its action leads to the inhibition of factors
promoting the pubertal pulsatile GnRH secretion [9].
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Phenotype related to MKRN3 mutations has not been
completely elucidated given the paucity of the report
published after the first description [10–13].
We report a new mutation (Pro160Cysfs*14) in the
maternally imprinted MKRN3 gene causing CPP in a girl
and her cousin, and precocious menarche in her paternal
grandmother.
Case presentation
A girl of Italian origin was examined at age of 7 years
for premature thelarche. The thelarche appeared when
the patient was 6 years old.
When the girl came to our observation, she showed
breast Tanner stage 3 and pubic hair stage 1. Her bone
age evaluated by TW2 method was 10 years and 3 months.
Anthropometric parameters are shown in Table 1. Fifth
fingers clinodactily of hands and lumbar hyperlordosis
represented additional clinical signs.
Diagnosis of CPP was performed on the basis of
hormonal data and pelvic ultrasound (Table 1). Thyroid
hormones and adrenal steroids were normal. Brain Mag-
netic Resonance (MRI) did not disclose any abnormality
both at hypothalamic and pituitary level. Treatment
with Gonadotrophin‐releasing hormone agonists analog
(GnRHa) was started (3.75 mg of the long-acting GnRHa
depot triptorelin once a month, intramuscular route).
Maternal menarche age (12 years) and father pubertal
development were normal, but we identified a 35 years
old female cousin belonging to the paternal side who
showed hormonal confirmed central precocious puberty
(LH 3.9 IU/L, FSH 4.2 IU/L, Estradiol 35 pg/mL) and
premature menarche when she was 7 years old (Fig. 1).
Her parents had both normal puberty onset. Considering
this medical history, we suspected a genetic cause for
the CPP, and, therefore, we focused on MKRN3. The
extended family was investigated. Assent was obtained
from the children and informed consent was obtained
from the adults involved in the study. The ethical com-
mittee of the Second University of Naples approved the
study.
Genomic DNA was extracted from peripheral blood leu-
kocytes. The encoding region of the intronless MKRN3
gene was amplified by overlapping primer pairs using
standard PCR protocols, followed by direct sequencing of
the purified PCR products.
We found a novel heterozygous mutation consisting in
a deletion of 8 bp (c477_485del). It was a frameshift mu-
tation and resulted in a premature stop codon leading to
a truncated protein (Pro160Cysfs*14) with a predicted
lack of both the C3HC4 RING motif and MKRN-
specific Cys–His domain. Using the prediction models
SIFT (Copyright 1993–2010, Fred Hutchinson Cancer
Research Center, Seattle, WA, USA) and Provean
(http://provean.jcvi.org), the P160Cfs*14 mutation has a
deleterious effect consistent with the synthesis of a trun-
cated and non-functional protein (score −13.5; threshold
for deleterious effect: below −2.5). Both the proband and
her cousin inherited the mutation from their fathers. In
accordance with the expected pattern of inheritance, the
fathers themselves reported to have normal puberty as
they inherited the mutation from their mother (Fig. 1).
Finally the grandmother reported precocious menarche
(9 years and 6 months) and interestingly, premature
menopause at 36 years. No clinical and biochemical data
about the grandmother are available.
Conclusion
Currently, 13 different loss-of-function mutations of
MKRN3 have been described in 30 patients with CPP
from 17 multiplex families, including 7 frameshift de-
fects, 4 missense mutations and 1 nonsense mutation
[7, 10–13]. This kind of mutations, therefore, represent
the most common cause of familial CPP.
We describe a family with CPP harboring a new muta-
tion of the MKRN3 gene. The frameshift mutation we
found was located in the amino-terminal region of the
protein, codified by a rich poly C site. In this region
other three mutations have been found, suggesting that
this area can be a potential hot spot.
A variable onset of precocious puberty has been shown
in the mutated subjects of the same family. The paternal
side female cousin (III.1 in Fig. 1) and the grandmother
(I.2 in Fig. 1) presented menarche when they were 7 and
9 years old respectively, while the proband (patient III.3)
Table 1 Clinical and laboratory characteristics of the proband
with the MKRN3 mutation
Patient III.3
At onset Age ( Years) 6
At referral Age (years) 7
Weight (kg) 28.9 (25-50th)
Height (cm ) 136.6(>97th)
Bone age (years) 10.3
Tanner stage B 3
Pubarche stage PH 1
Hormonal profile Basal LH (IU/L) 4.1
Basal FSH ( IU/L) 7.6
Estradiol (pg/mL) 29.7
Pelvic ultrasound Uterine transverse
diameter (cm)
2.2
Uterine length (cm) 4.0
Left Ovary (ml) 2
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presented thelarche onset at the age of 6 years. In
addition, the proband showed mild dysmorphisms (i.e.;
clinodactily and hyperlordosis). Among the other three
reported patients carrying MKRN3 loss of function mu-
tations, one had clinodactily and hyperlordosis whereas
the remaining two patients had esotropia [7, 11].
The mutated grandmother had also premature ovarian
failure. This clinical feature has not been previously
detected in patients with MKRN3 mutations. Although
the association with premature ovarian failure is purely
speculative at the moment, it is interesting to note that
in in PWS patients gonadal failure has been described as
part of the clinical spectrum [14]. Of course, the link
between the MKRN3 mutation and premature ovarian
failure has to be confirmed studying large cohorts of
adult mutated patients.
In our case the familial nature of the CPP was evident
only by the presence of a second degree and a third
degree relative affected from the paternal side, as parents
were asymptomatic and the girl had no siblings. Our
finding confirms a previous suspicion that the familial
nature of CPP can be frequently under-recognized if
not carefully investigated [11]. Most children with CPP
present for medical consultation accompanied by their
mothers. Their paternal family history, therefore, may be
often unknown, unavailable or under-investigated.
Due to maternal imprinting, only the paternal MKRN3
allele is expressed. CPP, therefore, can manifest only if the
mutated MKRN3 allele comes from father. Nevertheless,
fathers can be asymptomatic carriers if they have inherited
the mutated allele form their mothers, as in our family. So
we highlight the importance of an accurate family history
that can unravel the familiar nature of CPP also in cases
that seem sporadic. The determination of the precise
onset of puberty in boys and in their fathers it is not sim-
ple since testicular enlargement is not as obvious as breast
development and menarche in girls. So also when the
father had precocious puberty, it could be not reported
and only a very careful family medical history can reveal
the presence of subjects with precocious puberty in sec-
ond or third degree relatives.
Physicians should be aware of this kind of inheritance
in CPP with the aim to promote MKRN3 genetic ana-
lysis, providing an additional tool for the diagnosis and
adequate treatment of children with CPP.
The identification and the long-term follow-up of new
patients with MKRN3 defects and CPP could be very
interesting not only for the clarification of the pheno-
types according with different kinds of mutations but
also for establishing their risk of metabolic disorders and
estrogen-dependent tumor development later in life.
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Fig. 1 Pedigree of the family with the novel mutation of MKRN3 gene. Squares indicate male family members. Circles indicate females. Black
symbols indicate patients with CPP and, in case of the grandmother, with precocious menarche. Symbol with black points inside indicate the
asymptomatic carriers. White symbols indicate non mutated patients. The arrow indicates the proband
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